LncRNA GATA6-AS inhibits cancer cell proliferation and promotes cancer cell apoptosis in cervical cancer by down-regulating miR-205
Abstract Background Dysregulated endothelial cell growth is involved in many types of human cancer, including cervical cancer. LncRNA GATA6-AS was reported to regulate endothelial cell growth, suggesting it might involve in cervical cancer. Our study was carried out to explore the involvement of GAT...
Saved in:
Main Authors: | , , |
---|---|
Format: | Book |
Published: |
BMC,
2020-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_a1e08edbc3d64ae68dfa63d38e522f3a | ||
042 | |a dc | ||
100 | 1 | 0 | |a Xiaoying Zhao |e author |
700 | 1 | 0 | |a Huzhong Zheng |e author |
700 | 1 | 0 | |a Jun Chen |e author |
245 | 0 | 0 | |a LncRNA GATA6-AS inhibits cancer cell proliferation and promotes cancer cell apoptosis in cervical cancer by down-regulating miR-205 |
260 | |b BMC, |c 2020-11-01T00:00:00Z. | ||
500 | |a 10.1186/s12905-020-01082-7 | ||
500 | |a 1472-6874 | ||
520 | |a Abstract Background Dysregulated endothelial cell growth is involved in many types of human cancer, including cervical cancer. LncRNA GATA6-AS was reported to regulate endothelial cell growth, suggesting it might involve in cervical cancer. Our study was carried out to explore the involvement of GATA6-AS in cervical squamous cell carcinoma (CSCC), a subtype of cervical cancer. Methods To explore the expression of GATA6-AS, RT-qPCR was performed to detect GATA6-AS in plasma of 65 CSCC patients and 58 healthy females. To detect the expression of GATA6-AS, total RNAs were extracted. Results We found that plasma GATA6-AS expression was down-regulated in CSCC patients than that in healthy females, and HPV infection did not significantly affect the plasma expression of GATA6-AS. Moreover, we found that plasma GATA6-AS showed diagnostic values for CSCC by performing ROC curve analysis. The expression of miR-205 in plasma was also found to be up-regulated in CSCC patients than that in healthy females and inversely correlated with the expression of GATA6-AS in CSCC patients. Furthermore, over-expression of miR-205 did not significantly affect the expression of GATA6-AS in CSCC cells, while over-expression of GATA6-AS down-regulated miR-205 expression. In addition, GATA6-AS over-expression inhibited CSCC cell proliferation and promoted CSCC cell apoptosis, while miR-205 over-expression played opposite roles and attenuated the effects of GATA6-AS over-expression on CSCC cells. Conclusion Taken together, these results suggest that GATA6-AS may inhibit cell proliferation and promote cell apoptosis in CSCC by down-regulating miR-205. | ||
546 | |a EN | ||
690 | |a CSCC | ||
690 | |a GATA6-AS | ||
690 | |a miR-205 | ||
690 | |a Proliferation | ||
690 | |a Apoptosis | ||
690 | |a Gynecology and obstetrics | ||
690 | |a RG1-991 | ||
690 | |a Public aspects of medicine | ||
690 | |a RA1-1270 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n BMC Women's Health, Vol 20, Iss 1, Pp 1-6 (2020) | |
787 | 0 | |n http://link.springer.com/article/10.1186/s12905-020-01082-7 | |
787 | 0 | |n https://doaj.org/toc/1472-6874 | |
856 | 4 | 1 | |u https://doaj.org/article/a1e08edbc3d64ae68dfa63d38e522f3a |z Connect to this object online. |